glp 1 black friday deals Eden's Event is live! Save on select care programs, including up to $150 off GLP-1 care programs and $75 off NAD+ & sermorelin plans. Explore options that support your wellness Pricing

Moxit Shah, DM EndocrinologyConsultant Endocrinologist | Ahmedabad Appointment: 9979992797 Introduction For years, people struggling with obesity were told to "eat less and exercise more." While healthy lifestyle changes remain the foundation of weight management, modern science has shown that obesity is a chronic hormonal disease, not simply a lack of willpower

Purpose of Review The development of long-acting incretin receptor agonists represents a significant advance in the fight against the concurrent epidemics of type 2 diabetes mellitus (T2DM) and obesity

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical organizations to speak out about safety concerns.In December, the FDA released a statement to health care professionals and patients warning against the use of compounded and counterfeit versions of diabetes and obesity drugs, including semaglutide (Ozempic/Wegovy, Novo

Individualization is Key: The ADA strongly advocates tailoring HbA1c goals based on: Duration of diabetes Risk of hypoglycemia Life expectancy Comorbidities (cardiovascular disease, CKD) Patient preference and treatment burden Beyond HbA1c: Modern diabetes care increasingly integrates Continuous Glucose Monitoring (CGM) metrics such as Time in Range (TIR) alongside HbA1c

All marketed as "GLP-1 Supplements" even though they dont mimic GLP-1 at all

Drugs like Ozempic and Mounjaro have made regular headlines in recent years for their ability to facilitate weight loss often dramatic weight loss